Clincosm LogoSign in Get a demo

glomerulosclerosis, focal segmental

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glomerulosclerosis, Focal Segmental Trial in Worldwide (VX-147)

Completed
  • Glomerulosclerosis, Focal Segmental
  • Birmingham, Alabama
  • +43 more
Nov 10, 2022

Adult and Child Patients and Parents of Swelling Due to

Recruiting
  • Fluid Overload
  • +12 more
  • Interview
  • Ann Arbor, Michigan
    University of Michigan
Aug 16, 2022

Kidney Diseases, Diabetic Nephropathies, Glomerulosclerosis, Focal Segmental Trial in United States (GFB-887, Placebo)

Recruiting
  • Kidney Diseases
  • +10 more
  • Birmingham, Alabama
  • +75 more
Mar 29, 2022

Nephrotic Syndrome Study Network

Recruiting
  • Minimal Change Disease (MCD)
  • +2 more
  • Kidney Biopsy
  • Los Angeles, California
  • +34 more
Jan 3, 2022

Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome Trial in Cologne (Biosampling)

Recruiting
  • Glomerulosclerosis, Focal Segmental
  • +2 more
  • Biosampling
  • Cologne, NRW, Germany
    University Hospital of Cologne
Nov 12, 2021

Understand Genetics and Clinical Course of Focal Segmental

Terminated
  • Glomerulosclerosis, Focal Segmental
  • +2 more
  • FSGS/TR-MCD
  • Diabetic Nephropathy (DN)
  • Mesa, Arizona
  • +17 more
Jul 17, 2021

Collapsing Glomerulopathy, Glomerulosclerosis, Focal Segmental Trial run by the NIDDK (Isotretinoin)

Completed
Has Results
  • Collapsing Glomerulopathy
  • Glomerulosclerosis, Focal Segmental
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 12, 2017

Glomerulosclerosis, Focal Segmental Trial in Canada, United States (Losmapimod)

Completed
Has Results
  • Glomerulosclerosis, Focal Segmental
  • Los Angeles, California
  • +11 more
May 11, 2017